2-BROMOIMIDAZO[1,2-A]PYRIDINE-7-CARBOXYLIC ACID, 95.0%, 1g

4'-Fluoro-3'-methoxyacetophenone, 98.0%, 10g

4-(Azetidin-3-yl)morpholine dihydrochloride, 95.0%, 25g

(S,Z)-3-(((1R,3aR,3'R,4R,7aR)-7a-Methyl-1-((R)-6-methylheptan-2-yl)octahydrospiro[indene-4,2'-oxiran]-3'-yl)methylene)-4-methylenecyclohexan-1-ol, 97%, 5mg

2-Chloro-5-iodo-1H-benzo[d]imidazole, 95.0%, 100mg

C -(1,3-Dimethyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 10g

Chlorocarbonylsulfenyl chloride, 97.0%, 1g

(5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3-ylmethyl)amine dihydrochloride hydrate, 95.0%, 250mg

2-Bromo-6-methyl-5-nitropyridine, 98.0%, 5g

N-(3-Fluorophenyl)piperidin-4-amine hydrochloride, 95.0%, 10g

4-Cyclopropyl-1,2,3,4-tetrahydroquinoxalin-2-one, 98%, 250mg

1-Boc-4-methyl-piperidine-4-carboxylic acid, 97.0%, 25g

2-Nitrophenyl-beta-D-glucopyranoside, min. 99%, for biochemistry, 500 mg, glass packaging